BackClarus Therapeutics Holdings Overview

Clarus Therapeutics Holdings Inventory

Clarus Therapeutics Holdings's inventory is $17M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$16.80M
↑ 72.16% YoYΔ $7.04M vs prior year quarter

Peer average / median

Loading

Clarus Therapeutics Holdings Inventory History

Loading

Clarus Therapeutics Holdings vs. peers: Inventory Comparison

Loading

Clarus Therapeutics Holdings Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Clarus Therapeutics Holdings (CRXT) FAQ

As of the most recent data (June 2022), CRXT shows a inventory of $17M. That compares with $9.8M in the prior-year period — up 72.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CRXT's inventory is now $17M (was $9.8M) — a 72.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Clarus Therapeutics Holdings is outperforming or lagging.

Tracking CRXT's inventory over time shows whether Clarus Therapeutics Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $17M That compares with $9.8M in the prior-year period — up 72.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Clarus Therapeutics Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $17M) with ownership activity and broader fundamentals.